Thursday 19th April 2018 from 12:30pm
Baglioni Hotel Carlton
Via Senato, 5 - Milan
(MM1 San Babila)
Guest of honour and speaker:
Chairman & CEO of GENENTA Science
and Co-Founder of AurorA-TT
Topics of his speech:
"Biotech made in Italy: il caso vincente della startup valutata quasi 500 milioni di euro che conquista il mercato USA grazie alla sinergia tra scienza e management; e gli altri bio-unicorni italiani.
L'infanzia dell'ecosistema del trasferimento tecnologico italiano - un enorme valore da estrarre."
-20 years as a Leader in Venture Capital, Financial industry, and as Biotech Entrepreneur in the Italian market
-Founder & CEO of Quantica, the first Italian VC firm exclusively dedicated to research and academic spin-out companies
EOS – Ethical Oncology Science, acquired by Clovis Oncology for 420M$ + 80M$ upfront
Banzai Group 250M€ IPO
-Co-Founder and CEO of Genenta Science, spin-out from San Raffaele Hospital: gene therapy for tumor treatment (17M€ raised)
-Independent Member of the Research and Innovation Commission at the Italian Ministry of Health
-Board Member at Assobiotec and coordinator of the SMEs group
-Co-founder of AurorA-TT, Tech Transfer biotech investment firm
To confirm your attendance please complete the form below by Tuesday 17th April. If you wish to bring a GUEST, please write her/his details in the "Notes" field.
The cost of the lunch, €50, should be paid to the Hotel on the day.
In order to avoid bottle necks at the business lunch you are kindly requested to complete in advance this form and return it to [email protected] or bring it with you on the day.
Please note that cancellations are required by midday Wednesday 18th April at the latest otherwise you will be charged for the cost of the lunch.
Please do not hesitate to contact Maria Luisa Fantoni, Marketing & Communication, if you have any queries: Tel 02 877798 - [email protected]
Data sent successfully!
You will soon receive a confirmation email.